Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,302 INR | -0.52% | -2.70% | -3.97% |
24/05 | Caplin Point Arm Gets US FDA's Nod for Phenylephrine Hydrochloride Ophthalmic Solution | MT |
16/05 | Caplin Point Laboratories to Seek Acquisitions | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-3.97% | 1.19B | |
+18.04% | 43.07B | |
+16.92% | 21.51B | |
+18.33% | 15.19B | |
+19.27% | 14.44B | |
+56.12% | 13.12B | |
-10.73% | 6.79B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+7.31% | 4.73B |
- Stock Market
- Equities
- CAPLIPOINT Stock
- News Caplin Point Laboratories Limited
- Caplin Point Gets Four Observations from US FDA After Inspection of Injectable Unit at Gummidipoondi, India